ALBIREO PHARMA, INC.·4

Jan 25, 8:10 PM ET

Carter Martha J. 4

4 · ALBIREO PHARMA, INC. · Filed Jan 25, 2023

Insider Transaction Report

Form 4
Period: 2023-01-19
Carter Martha J.
Chief Regulatory Officer
Transactions
  • Award

    Common Stock

    2023-01-19+55,00069,506 total
Footnotes (2)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, with the remainder vesting in equal installments every three months thereafter beginning on April 19, 2024 and ending on January 19, 2027.
  • [F2]Represents 3,656 shares of common stock and 65,850 restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION